61 related articles for article (PubMed ID: 18242964)
1. Factors affecting release rate of diltiazem hydrochloride from poly (2-hydroxyethyl methacrylate) matrices.
Yanagawa F; Ishii Y; Onuki Y; Morishita M; Takayama K
Colloids Surf B Biointerfaces; 2008 May; 63(1):146-52. PubMed ID: 18242964
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol-modified superporous poly(2-hydroxyethyl methacrylate) scaffolds for tissue engineering.
Kubinová S; Horák D; Syková E
Biomaterials; 2009 Sep; 30(27):4601-9. PubMed ID: 19500833
[TBL] [Abstract][Full Text] [Related]
3. [The release behavior of the combined system of diltiazem hydrochloride delayed-onset sustained-release pellets and modeling by mathematics method].
Chen SJ; Zhu JB
Yao Xue Xue Bao; 2005 Jul; 40(7):606-10. PubMed ID: 16196265
[TBL] [Abstract][Full Text] [Related]
4. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
[TBL] [Abstract][Full Text] [Related]
5. Controlled slow release of chemotherapeutic drugs for cancer from matrices prepared by radiation polymerization at low temperatures.
Kaetsu I; Yoshida M; Yamada A
J Biomed Mater Res; 1980 May; 14(3):185-97. PubMed ID: 6154055
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of diltiazem hydrochloride in solid phase.
Muszalska I; Siakowski M
Acta Pol Pharm; 2003; 60(1):27-30. PubMed ID: 12848364
[TBL] [Abstract][Full Text] [Related]
7. Macromolecule release and smoothness of semi-interpenetrating PVP-pHEMA networks for comfortable soft contact lenses.
Yañez F; Concheiro A; Alvarez-Lorenzo C
Eur J Pharm Biopharm; 2008 Aug; 69(3):1094-103. PubMed ID: 18359212
[TBL] [Abstract][Full Text] [Related]
8. Field-gradient NMR diffusometry in poly(ethylene oxide) melts confined to nanoscopic pores of solid methacrylate matrices.
Fischer E; Beginn U; Fatkullin N; Kimmich R
Magn Reson Imaging; 2005 Feb; 23(2):379-81. PubMed ID: 15833653
[TBL] [Abstract][Full Text] [Related]
9. Controlled release of drugs from multi-component biomaterials.
Zalfen AM; Nizet D; Jérôme C; Jérôme R; Frankenne F; Foidart JM; Maquet V; Lecomte F; Hubert P; Evrard B
Acta Biomater; 2008 Nov; 4(6):1788-96. PubMed ID: 18583206
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of hydrolysis of diltiazem hydrochloride in aqueous solutions.
Muszalska I; Jamszoł L; Grześkowiak D
Acta Pol Pharm; 2003; 60(3):163-8. PubMed ID: 14556482
[TBL] [Abstract][Full Text] [Related]
11. Application of a novel symmetrical shape factor to gastroretentive matrices as a measure of swelling synchronization and its impact on drug release kinetics under standard and modified dissolution conditions.
Liu Q; Fassihi R
J Pharm Pharmacol; 2009 Jul; 61(7):861-7. PubMed ID: 19589227
[TBL] [Abstract][Full Text] [Related]
12. Anomalous release of hydrophilic drugs from poly(epsilon-caprolactone) matrices.
Rosenberg R; Devenney W; Siegel S; Dan N
Mol Pharm; 2007; 4(6):943-8. PubMed ID: 17960890
[TBL] [Abstract][Full Text] [Related]
13. In situ synthesis of hybrid nanocomposite with highly order arranged amorphous metallic copper nanoparticle in poly(2-hydroxyethyl methacrylate) and its potential for blood-contact uses.
Liu YY; Liu DM; Chen SY; Tung TH; Liu TY
Acta Biomater; 2008 Nov; 4(6):2052-8. PubMed ID: 18585991
[TBL] [Abstract][Full Text] [Related]
14. Involvement of fractal geometry on solute permeation through porous poly (2-hydroxyethyl methacrylate) membranes.
Yanagawa F; Onuki Y; Morishita M; Takayama K
J Control Release; 2006 Jan; 110(2):395-399. PubMed ID: 16332400
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of diltiazem hydrochloride-loaded mucoadhesive microspheres prepared by emulsification-internal gelation technique.
Das MK; Maurya DP
Acta Pol Pharm; 2008; 65(2):249-59. PubMed ID: 18666434
[TBL] [Abstract][Full Text] [Related]
16. Influence of Organic Acids on Diltiazem HCl Release Kinetics from Hydroxypropyl Methyl Cellulose Matrix Tablets.
Sateesha S; Rajamma A; Narode M; Vyas B
J Young Pharm; 2010 Jul; 2(3):229-33. PubMed ID: 21042476
[TBL] [Abstract][Full Text] [Related]
17. Rapid deswelling response of poly(N-isopropylacrylamide)/poly(2-alkyl-2-oxazoline)/poly(2-hydroxyethyl methacrylate) hydrogels.
David G; Simionescu BC; Albertsson AC
Biomacromolecules; 2008 Jun; 9(6):1678-83. PubMed ID: 18481892
[TBL] [Abstract][Full Text] [Related]
18. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
Kranz H; Bodmeier R
Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
[TBL] [Abstract][Full Text] [Related]
19. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
[TBL] [Abstract][Full Text] [Related]
20. Excited-state proton-transfer dynamics of 1-methyl-6-hydroxyquinolinium embedded in a solid matrix of poly(2-hydroxyethyl methacrylate).
Park SY; Lee YS; Jang DJ
Phys Chem Chem Phys; 2008 Nov; 10(44):6703-7. PubMed ID: 18989483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
